ORAOV1 Antikörper (Internal Region)
ORAOV1
Reaktivität: Human
WB, ELISA, IF, IHC
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN7187669
-
-
Target
Alle ORAOV1 Produkte
-
ORAOV1
(Oral Cancer Overexpressed 1 (ORAOV1))
-
Bindungsspezifität
-
Internal Region
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser ORAOV1 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (IHC)
-
Kreuzreaktivität
-
Human
-
Aufreinigung
-
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
-
Synthesized peptide derived from the Internal region of Human ORAOV1.
-
Isotyp
-
IgG
-
-
-
Applikationshinweise
-
WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:10000,
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Buffer
-
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
-20 °C,-80 °C
-
Informationen zur Lagerung
-
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
Target
-
ORAOV1
(Oral Cancer Overexpressed 1 (ORAOV1))
-
Andere Bezeichnung
-
ORAOV1 (ORAOV1 Produkte)
-
Synonyme
-
TAOS1 antikoerper, 2210010N10Rik antikoerper, oral cancer overexpressed 1 antikoerper, ORAOV1 antikoerper, Oraov1 antikoerper
-
Hintergrund
-
LTO1 antibody, ORAOV1 antibody, TAOS1Protein LTO1 homolog antibody, Oral cancer-overexpressed protein 1 antibody, Tumor-amplified and overexpressed sequence 1 antibody
-
UniProt
-
Q8WV07
-